Zimmer Biomet (ZBH) Financials: Revenue & Earnings
ZBH$96.88+0.49 +0.51%
$18.48B
Market Cap
23.26
P/E
11.35
Forward P/E
58
Score
Zimmer Biomet (ZBH) Financials: Revenue & Earnings
ZBH price $96.88 +0.49 +0.51%
- Ticker
- ZBH
- Price
- $96.88
- Change
- +0.49 +0.51%
- Market cap ?
- $18.48B
- P/E ?
- 23.26
- Forward P/E ?
- 11.35
- Dividend yield ?
- 1.00%
- Beta ?
- 0.48
- Sector
- Healthcare
- Industry
- Medical - Devices
- Stocklytics score
- 58
- Value
- 70
- Quality
- 52
- Growth
- 51
Stocklytics score rationale: value 70, quality 52, growth 51.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 7668400000 | 7803300000 | 7932900000 | 7982200000 | 6127500000 | 6827300000 | 6939900000 | 7394200000 | 7678600000 | 8231500000 |
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and…
Earnings and financials
Zimmer Biomet Holdings, Inc. (ZBH) trades at $96.88, with a market cap of $18.48B and a trailing P/E of 23.26. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 7668400000 | 7803300000 | 7932900000 | 7982200000 | 6127500000 | 6827300000 | 6939900000 | 7394200000 | 7678600000 | 8231500000 |
Insights · Dividends · Forecast · Financials · Learn